Literature DB >> 7907246

CD4 T cell count as predictor of Pneumocystis carinii pneumonia in children born to mothers infected with HIV. European Collaborative Study Group.

.   

Abstract

OBJECTIVE: To assess the value of CD4 T cell count in predicting Pneumocystis carinii pneumonia in infants born to mothers infected with HIV, with reference to the guidelines from the Centers for Disease Control on prophylaxis against pneumocystis.
DESIGN: Prospective birth cohort study.
SETTING: Hospitals in 10 European cities participating in the European collaborative study.
SUBJECTS: 924 children born to mothers known to be infected with HIV at or before delivery. MAIN OUTCOME MEASURES: The incidence of P carinii pneumonia. CD4 T cell counts in children before diagnosis of the pneumonia. The proportions of children infected and uninfected with HIV who fulfilled the criteria for primary prophylaxis.
RESULTS: Fourteen children were diagnosed with P carinii pneumonia. The cumulative incidence by the age of 6 years was 2% (95% confidence interval 0.9 to 3.0%). Of the 11 children with a CD4 T cell count predating diagnosis, only three fulfilled the criteria from the Centers for Disease Control for prophylaxis. Prophylaxis was indicated by 1 year of age for 62% of infected children who had not developed P carinii pneumonia and for at least 10% of uninfected children.
CONCLUSIONS: Monitoring CD4 T cell count seems to be of limited value in deciding when to start prophylaxis against P carinii pneumonia in children born to mothers infected with HIV. The alternative approach of giving prophylaxis to all children born to infected mothers would be difficult to justify given the low incidence of the pneumonia.

Entities:  

Mesh:

Year:  1994        PMID: 7907246      PMCID: PMC2539523     

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  13 in total

Review 1.  Pneumocystis carinii pneumonia: new approaches to diagnosis, treatment and prevention.

Authors:  W T Hughes
Journal:  Pediatr Infect Dis J       Date:  1991-05       Impact factor: 2.129

2.  Pneumocystis carinii pneumonia in infants infected with the human immunodeficiency virus with more than 450 CD4 T lymphocytes per cubic millimeter.

Authors:  E Leibovitz; M Rigaud; H Pollack; R Lawrence; S Chandwani; K Krasinski; W Borkowsky
Journal:  N Engl J Med       Date:  1990-08-23       Impact factor: 91.245

Review 3.  Pneumocystis carinii pneumonia despite prophylaxis in children with human immunodeficiency virus infection.

Authors:  B U Mueller; K M Butler; R N Husson; P A Pizzo
Journal:  J Pediatr       Date:  1991-12       Impact factor: 4.406

4.  Prognostic factors and life expectancy in children with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia.

Authors:  L J Bernstein; M R Bye; A Rubinstein
Journal:  Am J Dis Child       Date:  1989-07

5.  Prognostic significance of immunologic changes in 675 infants perinatally exposed to human immunodeficiency virus. The Italian Register for Human Immunodeficiency Virus Infection in Children.

Authors:  M de Martino; P A Tovo; L Galli; C Gabiano; S Cozzani; C Gotta; G Scarlatti; A Fiocchi; P Cocchi; P Marchisio
Journal:  J Pediatr       Date:  1991-11       Impact factor: 4.406

6.  Clinical and laboratory correlates of Pneumocystis carinii pneumonia in children infected with HIV.

Authors:  E Connor; M Bagarazzi; G McSherry; B Holland; M Boland; T Denny; J Oleske
Journal:  JAMA       Date:  1991-04-03       Impact factor: 56.272

7.  CD4 T-lymphocyte counts and Pneumocystis carinii pneumonia in pediatric HIV infection.

Authors:  A Kovacs; T Frederick; J Church; A Eller; M Oxtoby; L Mascola
Journal:  JAMA       Date:  1991-04-03       Impact factor: 56.272

8.  Vertically transmitted HIV infection in the British Isles.

Authors:  A E Ades; C F Davison; F J Holland; D M Gibb; C N Hudson; A Nicholl; D Goldberg; C S Peckham
Journal:  BMJ       Date:  1993-05-15

9.  Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important.

Authors:  J L Malone; T E Simms; G C Gray; K F Wagner; J R Burge; D S Burke
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

10.  The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group.

Authors:  J Phair; A Muñoz; R Detels; R Kaslow; C Rinaldo; A Saah
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

View more
  2 in total

1.  Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life.

Authors:  A Bamford; A Turkova; H Lyall; C Foster; N Klein; D Bastiaans; D Burger; S Bernadi; K Butler; E Chiappini; P Clayden; M Della Negra; V Giacomet; C Giaquinto; D Gibb; L Galli; M Hainaut; M Koros; L Marques; E Nastouli; T Niehues; A Noguera-Julian; P Rojo; C Rudin; H J Scherpbier; G Tudor-Williams; S B Welch
Journal:  HIV Med       Date:  2015-02-03       Impact factor: 3.180

2.  Prophylaxis of Pneumocystis carinii pneumonia in HIV-infected children one to five years old: a multicenter surveillance study in paediatric hospitals in Germany.

Authors:  N Rümmelein; U Wintergerst; B H Belohradsky
Journal:  Infection       Date:  1998 Mar-Apr       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.